Gene · 9775
Papers1,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Eukaryotic initiation factor 4 A-3 promotes glioblastoma growth and invasion through the Notch1-dependent pathway. | BMC Cancer | 2023 | 37322413 | PubTator, text mining | PubMed |
| N-terminal proteoforms may engage in different protein complexes. | Life Sci Alliance | 2023 | 37316325 | PubTator, text mining | PubMed |
| Circ-SHPRH in human cancers: a systematic review and meta-analysis. | Front Cell Dev Biol | 2023 | 37305675 | PubTator, text mining | PubMed |
| CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets. | Cell Death Dis | 2023 | 37296107 | PubTator, text mining | PubMed |
| The paralogues MAGOH and MAGOHB are oncogenic factors in high-grade gliomas and safeguard the splicing of cell division and cell cycle genes. | RNA Biol | 2023 | 37294214 | PubTator, text mining | PubMed |
| EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway. | Biomark Res | 2023 | 37280654 | PubTator, text mining | PubMed |
| Impact of climate change on shumbrite small scale irrigation project, South Gojjam subbasin, Ethiopia. | Heliyon | 2023 | 37251898 | PubTator, text mining | PubMed |
| LncRNA CASC2 Inhibits Progression of Glioblastoma by Regulating the Expression of AKT in T98G Cell Line, Treated by TMZ and Thiosemicarbazone Complex. | Asian Pac J Cancer Prev | 2023 | 37247274 | PubTator, text mining | PubMed |
| EIF4A3-Induced Exosomal circLRRC8A Alleviates Granulosa Cells Senescence Via the miR-125a-3p/NFE2L1 axis. | Stem Cell Rev Rep | 2023 | 37243831 | PubTator, text mining | PubMed |
| Clinical Application of Circular RNAs as Biomarkers in Acute Ischemic Stroke. | J Pers Med | 2023 | 37241009 | PubTator, text mining | PubMed |
| Crosstalk between colorectal cancer cells and cancer-associated fibroblasts in the tumor microenvironment mediated by exosomal noncoding RNAs. | Front Immunol | 2023 | 37234178 | PubTator, text mining | PubMed |
| The role of regulators of RNA m6A methylation in lung cancer. | Genes Dis | 2023 | 37223516 | PubTator, text mining | PubMed |
| Editorial: Therapeutic targeting of splicing variants in cancer. | Front Pharmacol | 2023 | 37214461 | PubTator, text mining | PubMed |
| Regulatory mechanisms and clinical applications of tumor-driven exosomal circRNAs in cancers. | Int J Med Sci | 2023 | 37213665 | PubTator, text mining | PubMed |
| Serine-rich domain of RNPS1 functions in activation of alternative splicing. | Genes Cells | 2023 | 37204171 | PubTator, text mining | PubMed |
| Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients. | Cancer Cell Int | 2023 | 37194105 | PubTator, text mining | PubMed |
| Circular RNA circARHGEF28 inhibited the progression of prostate cancer via the miR-671-5p/LGALS3BP/NF-κB axis. | Cancer Sci | 2023 | 37186007 | PubTator, text mining | PubMed |
| EIF4A3 serves as a prognostic and immunosuppressive microenvironment factor and inhibits cell apoptosis in bladder cancer. | PeerJ | 2023 | 37180585 | PubTator, text mining | PubMed |
| Circ_0020256 induces fibroblast activation to drive cholangiocarcinoma development via recruitment of EIF4A3 protein to stabilize KLF4 mRNA. | Cell Death Discov | 2023 | 37179359 | PubTator, text mining | PubMed |
| New Insights into the Impact of Human Papillomavirus on Oral Cancer in Young Patients: Proteomic Approach Reveals a Novel Role for S100A8. | Cells | 2023 | 37174723 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9775/papers?page=15